Ignite Creation Date:
2024-05-06 @ 7:33 PM
Last Modification Date:
2024-10-26 @ 3:09 PM
Study NCT ID:
NCT06056297
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2023-09-20
Brief Title:
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent andor Serious Infections
Sponsor:
X4 Pharmaceuticals
Organization:
X4 Pharmaceuticals
Organization Data
Organization:
X4 Pharmaceuticals
Class:
INDUSTRY
Study ID:
X4P-001-110
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
X4 Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None